Ease Labs planning to raise BRL 40m in new funding round and double sales team by year's end
Ease Labs planeja captar BRL 40m em nova rodada e dobrar time de vendas até o final do ano
Intel ID : 352633
|
||||
| Intel ID | 352633 | ||
| Value | EUR 7,75m | ||
| Native Currency |
Brazilian Real (BRL)
Exchange Rate:  |
||
|
Financial Data - Elepar Consultoria e Participações
(31 Dec 2022) |
Exchange Rate:
|
||
| Date |
|
||
| Country | |
||
| Geography | |
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Subsector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution (Primary) 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Type |
 |
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.